key: cord-0845992-ln77rbq1
authors: nan
title: Reducing surgical site infections in low-income and middle-income countries (FALCON): a pragmatic, multicentre, stratified, randomised controlled trial
date: 2021-11-06
journal: Lancet
DOI: 10.1016/s0140-6736(21)01548-8
sha: 501eeeaf260e8be3d88d178536ca08edd39e91ce
doc_id: 845992
cord_uid: ln77rbq1

BACKGROUND: Surgical site infection (SSI) is the most common postoperative complication worldwide. WHO guidelines to prevent SSI recommend alcoholic chlorhexidine skin preparation and fascial closure using triclosan-coated sutures, but called for assessment of both interventions in low-resource settings. This study aimed to test both interventions in low-income and middle-income countries. METHODS: FALCON was a 2 × 2 factorial, randomised controlled trial stratified by whether surgery was clean-contaminated, or contaminated or dirty, including patients undergoing abdominal surgery with a skin incision of 5 cm or greater. This trial was undertaken in 54 hospitals in seven countries (Benin, Ghana, India, Mexico, Nigeria, Rwanda, and South Africa). Patients were computer randomised 1:1:1:1 to: (1) 2% alcoholic chlorhexidine and non-coated suture, (2) 2% alcoholic chlorhexidine and triclosan-coated suture, (3) 10% aqueous povidone–iodine and non-coated suture, or (4) 10% aqueous povidone–iodine and triclosan-coated suture. Patients and outcome assessors were masked to intervention allocation. The primary outcome was SSI, reported by trained outcome assessors, and presented using adjusted relative risks and 95% CIs. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, NCT03700749. FINDINGS: Between Dec 10, 2018, and Sept 7, 2020, 5788 patients (3091 in clean-contaminated stratum, 2697 in contaminated or dirty stratum) were randomised (1446 to alcoholic chlorhexidine and non-coated suture, 1446 to alcoholic chlorhexidine and triclosan-coated suture, 1447 to aqueous povidone–iodine and non-coated suture, and 1449 to aqueous povidone–iodine and triclosan-coated suture). 14·0% (810/5788) of patients were children and 66·9% (3873/5788) had emergency surgery. The overall SSI rate was 22·0% (1163/5284; clean-contaminated stratum 15·5% [454/2923], contaminated or dirty stratum 30·0% [709/2361]). For both strata, there was no evidence of a difference in the risk of SSI with alcoholic chlorhexidine versus povidone–iodine (clean-contaminated stratum 15·3% [223/1455] vs 15·7% [231/1468], relative risk 0·97 [95% CI 0·82–1·14]; contaminated or dirty stratum 28·3% [338/1194] vs 31·8% [371/1167], relative risk 0·91 [95% CI 0·81–1·02]), or with triclosan-coated sutures versus non-coated sutures (clean-contaminated stratum 14·7% [215/1459] vs 16·3% [239/1464], relative risk 0·90 [95% CI 0·77–1·06]; contaminated or dirty stratum 29·4% [347/1181] vs 30·7% [362/1180], relative risk 0·98 [95% CI 0·87–1·10]). With both strata combined, there were no differences using alcoholic chlorhexidine or triclosan-coated sutures. INTERPRETATION: This trial did not show benefit from 2% alcoholic chlorhexidine skin preparation compared with povidone–iodine, or with triclosan-coated sutures compared with non-coated sutures, in preventing SSI in clean-contaminated or contaminated or dirty surgical wounds. Both interventions are more expensive than alternatives, and these findings do not support recommendations for routine use. FUNDING: National Institute for Health Research (NIHR) Global Health Research Unit Grant, BD.

• Hernia repair (no bowel resection anticipated) • Adhesiolysis

• Appendicectomy (noninflamed appendix anticipated) • Cholecystectomy (no bile spillage anticipated) • Bowel resection (no gross spillage of faeces anticipated) • Caesarean section • Appendicectomy (inflamed, nonperforated appendix anticipated) • Laparotomy for infarcted or necrotic bowel (no perforation anticipated)

• Laparotomy for perforated duodenal ulcer • Hartmann's procedure for perforated sigmoid colon • Old traumatic wounds with devitalized tissue

Recommended baseline technique • Skin should be free of gross contamination (dirt, soil, etc) before the application of any antiseptic agent. Patients with unclean skin should be washed first. • Perform hair removal with skin clippers (or equivalent) immediately prior to skin prep application. • Application of skin preparation should be started at the site of the incision (scrubbed for 30 seconds) followed by concentric circles to the sides of abdomen. •

Pooling of the prep solution underneath the patient should be avoided. •

The prep solution should be allowed to dry (for at least 2 minutes) before draping and before incision. • Do not blow or wipe off the prep solution. • Do not "double dip" into the antiseptic solution with a contaminated sponge.

Intervention: 2% alcoholic chlorhexidine. • This can be applied with either a swab on stick (e.g. Rampley sponge forceps) or via a 'Chloraprep stick' which will be supplied if required. • If the prepared area is >30 x 30cm, a second ChloraPrep stick may be required. • If preparation of a mucosal membrane is required (e.g. perianal part of a perineal incision), then 10% povidine-iodine may be used for this area only.

Comparator: 10% povidone-iodine. • This will be provided in 500ml bottles, from which up to 100ml will be dispensed into a sterile container within the surgical tray and applied using a swab (e.g. Rampley sponge forceps). • Any bottles used should be checked for use by date and discarded 30 days after opening (or per manufacturer's recommendation).

• In adults, PDS suture is used to provide a continuous fascial closure; this can either be looped or non-looped according to surgeon choice. • In children, a braided absorbable suture (e.g. Vicryl) is acceptable which may be applied as either a continuous or interrupted suture.

• Triclosan-coated PDS or Vicryl suture.

• Non-coated PDS or Vicryl suture. 

Stephen's Hospital, Delhi 6 (0.4) 8 (0.5) 8 (0.5) 9 (0.6) 10 (0.7) 12 (0.9) 12 (0.9) 10 (0. 

Subgroup analyses were planned for the primary outcome using two variables that were used for minimisation (excluding centre): Supplementary table 17a and 17b. Per-protocol sensitivity analysis for the primary outcome by wound contamination stratum for skin preparation (above) and fascial closure suture (below)

A per protocol analysis was performed as a sensitivity analysis, whereby participants that were not adherent to their randomised treatment will be excluded from the analysis population. Patients with missing information on actual intervention received have been classed as 'missing' 

table 22a and 22b. Surgical site infection (SSI) rates by country for primary outcome by treatment group and wound classification stratum for skin preparation (above) and fascial suture closure (below)

Statistical analysis (alphabetical): Pollyanna Hardy, Omar Omar Patient representatives (alphabetical): Emmy Runigamugabo

Arkorful Ebenezer Temitope Holy Family Hospital

Sreejith Veetil Christian Medical College

Johannesburg: Abdus-sami Adewunmi* Independent Data Monitoring and Ethics Committee (alphabetical)

Patients who were lost to follow-up, died before outcome assessment, or had missing primary outcome data could not be assessed for the primary outcome and were excluded from the intention to treat analysis 1 . Sensitivity analyses for patients with missing data (coding them as having a positive or negative primary outcome) are shown in Appendix 2. These patients could contribute to analysis of secondary outcomes if relevant data were available. A flowchart that illustrates withdrawals and exclusion at each stage is shown in figure 1.